Cite
HARVARD Citation
Eveillard, M. et al. (2020). Comparison of MALDI‐TOF mass spectrometry analysis of peripheral blood and bone marrow‐based flow cytometry for tracking measurable residual disease in patients with multiple myeloma. British journal of haematology. pp. 904-907. [Online].